Jun Ye
Impact in
- Drug Discovery top 2%
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 15
- Silk-based biomaterials and applications 4
-
- Advanced Drug Delivery Systems 9
- Drug Solubulity and Delivery Systems 7
- Co-authors
- Yuling Liu (10 shared papers)Yanfang Yang (25 shared papers)Lili Gao (9 shared papers)Xuejun Xia (16 shared papers)Wujun Dong (13 shared papers)Yuling Liu (14 shared papers)Yue Gao (8 shared papers)Hongliang Wang (13 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (5 papers)Journal of Pharmaceutical Analysis (4 papers)International Journal of Nanomedicine (4 papers)Journal of Controlled Release (3 papers)Chinese Chemical Letters (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jun Ye
69 papers receiving 2k citations
Jun Ye's Hit Papers
Peers
Comparison fields: 5 of 109
- Drug Discovery 21
- Pharmaceutical Science 237
- Biomaterials 359
- Cancer Research 144
- Complementary and alternative medicine 97
Countries citing papers authored by Jun Ye
This map shows the geographic impact of Jun Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ye more than expected).
Fields of papers citing papers by Jun Ye
This network shows the impact of papers produced by Jun Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ye. The network helps show where Jun Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review Hit paper breakdown → | 2020 | 271 |
| 2 | 2017 | 187 | |
| 3 | 2017 | 101 | |
| 4 | 2016 | 94 | |
| 5 | 2024 | 94 | |
| 6 | 2019 | 90 | |
| 7 | 2019 | 76 | |
| 8 | 2019 | 68 | |
| 9 | 2023 | 66 | |
| 10 | 2017 | 60 | |
| 11 | 2016 | 58 | |
| 12 | 2012 | 57 | |
| 13 | 2019 | 55 | |
| 14 | 2018 | 42 | |
| 15 | 2021 | 40 | |
| 16 | 2016 | 37 | |
| 17 | 2016 | 30 | |
| 18 | 2018 | 30 | |
| 19 | 2020 | 30 | |
| 20 | 2023 | 29 |
About Jun Ye
Jun Ye is a scholar working on Biomaterials, Pharmaceutical Science, Immunology, Cancer Research and Genetics, having authored 76 papers that have together received 2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Advanced Drug Delivery Systems (9 papers), Drug Solubulity and Delivery Systems (7 papers), Immunotherapy and Immune Responses (5 papers), Inflammatory Bowel Disease (4 papers), Silk-based biomaterials and applications (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Drug Discovery (21 citations), Pharmaceutical Science (237 citations), Biomaterials (359 citations), Cancer Research (144 citations) and Complementary and alternative medicine (97 citations). Jun Ye has collaborated with scholars based in China and United States. Frequent co-authors include Yuling Liu, Yanfang Yang, Lili Gao, Xuejun Xia, Wujun Dong, Yuling Liu, Yue Gao, Hongliang Wang, Yuling Liu and Peiwei Li. Their work appears in journals such as Acta Pharmaceutica Sinica B, Journal of Pharmaceutical Analysis, International Journal of Nanomedicine, Journal of Controlled Release and Chinese Chemical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.